Deprivation and dialysis: Pathways to kidney failure in Australian Aborigines
To access this article, please choose from the options below
Dr. Thomas has received honoraria for lectures, research funding and conference attendance costs from a number of different pharmaceutical companies, including Amgen Australia, Astra-Zeneca, Boehringer Ingelheim, Fresenius Medical Care, Janssen-Cilag, Novartis, Sanofi-Synthelabo, Servier Laboratories, and Solvay Pharmaceuticals.
PII: S1548-5595(04)00180-6
doi:10.1053/j.ackd.2004.10.008
© 2005 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
